Medical Xpress September 17, 2025
Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications.
On Tuesday, the U.S. Food and Drug Administration (FDA) released more than 100 warning letters aimed at both drugmakers and online health companies. Among them: Hims & Hers, a telehealth platform that has made a name by selling lower-cost versions of well-known drugs, The Associated Press said.
The agency said Hims crossed the line by telling customers its compounded products contained “the same active ingredient” as Ozempic and Wegovy, even though Hims’ versions are mixed by compounding pharmacies and never reviewed by the FDA.
“Your claims imply that your products are the same as an FDA-approved product when they...
Today's Sponsors
Today's Sponsor